These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 1905737

  • 1. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
    Abs R, Parizel PM, Beckers A.
    J Endocrinol Invest; 1991 Feb; 14(2):135-8. PubMed ID: 1905737
    [Abstract] [Full Text] [Related]

  • 2. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M, Olchovsky D, Pines A, Tadmor R, Lunenfeld B.
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C, Lucas T, Alcañiz J, Davila N, Serrano P, Barcelò B, Estrada J.
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [Abstract] [Full Text] [Related]

  • 4. Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patients.
    Jamrozik SI, Bennet AP, James-Deidier A, Tremollieres F, Saint-Martin F, Dumoulin S, Valat-Coustols M, de Glisezinski I, Tremoulet M, Manelfe C, Louvet JP.
    J Endocrinol Invest; 1996 Feb; 19(7):472-9. PubMed ID: 8884542
    [Abstract] [Full Text] [Related]

  • 5. Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine.
    Vance ML, Ridgway EC, Thorner MO.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):580-4. PubMed ID: 2410444
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
    Schettini G, Lombardi G, Merola B, Miletto P, Fariello C, Cirillo S, Fusco R, Lancranjan I.
    J Endocrinol Invest; 1988 Jan; 11(1):47-51. PubMed ID: 3361075
    [Abstract] [Full Text] [Related]

  • 7. Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.
    Beckers A, Petrossians P, Abs R, Flandroy P, Stadnik T, de Longueville M, Lancranjan I, Stevenaert A.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):275-80. PubMed ID: 1619019
    [Abstract] [Full Text] [Related]

  • 8. Mixed pituitary tumours--effects of bromocriptine treatment: Parlodel MR and Parlodel LAR.
    Zgliczyński W, Zgliczyński S, Makowska A, Słowinska-Srzednicka J, Janik J, Jeske W, Walecki J.
    Endokrynol Pol; 1992 Jul; 43(3):242-9. PubMed ID: 1345565
    [Abstract] [Full Text] [Related]

  • 9. Resolution of possible paradoxical responses of gonadotropins to thyrotropin-releasing hormone with bromocriptine therapy in a patient with follicle-stimulating hormone-secreting pituitary adenoma.
    Mercado-Asis LB, Yasuda K, Ishizawa M, Ishizuka T, Murayama M, Shimokawa K, Miura K.
    Endocrinol Jpn; 1992 Aug; 39(4):401-6. PubMed ID: 1446655
    [Abstract] [Full Text] [Related]

  • 10. Primary treatment of macroprolactinomas with Parlodel LAR.
    van 't Verlaat JW, Lancranjan I, Hendriks MJ, Croughs RJ.
    Acta Endocrinol (Copenh); 1988 Sep; 119(1):51-5. PubMed ID: 3414319
    [Abstract] [Full Text] [Related]

  • 11. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
    Harris RI, Schatz NJ, Gennarelli T, Savino PJ, Cobbs WH, Snyder PJ.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924
    [Abstract] [Full Text] [Related]

  • 12. New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia.
    Zgliczyński W, Zgliczyński S, Makowska A, Słowinska-Srzednicka J, Janik J, Jeske W, Walecki J.
    Endokrynol Pol; 1992 Jun; 43(3):234-41. PubMed ID: 1345564
    [Abstract] [Full Text] [Related]

  • 13. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
    Bonneville JF, Poulignot D, Cattin F, Couturier M, Mollet E, Dietemann JL.
    Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
    [Abstract] [Full Text] [Related]

  • 14. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM, Scanlon MF, Hall K, Cook DB, Hall R.
    N Engl J Med; 1979 Feb 08; 300(6):291-3. PubMed ID: 759882
    [No Abstract] [Full Text] [Related]

  • 15. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA, Chang RJ.
    Obstet Gynecol; 1984 Sep 08; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [Abstract] [Full Text] [Related]

  • 16. Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.
    Halperin I, Rodriguez MD, Cardenal C, Casamitjana R, Martinez Osaba MJ, Lienas V, Vilardell E.
    J Endocrinol Invest; 1987 Jun 08; 10(3):277-82. PubMed ID: 3040850
    [Abstract] [Full Text] [Related]

  • 17. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro.
    Lamberts SW, Verleun T, Oosterom R, Hofland L, van Ginkel LA, Loeber JG, van Vroonhoven CC, Stefanko SZ, de Jong FH.
    J Clin Endocrinol Metab; 1987 Mar 08; 64(3):524-30. PubMed ID: 3102540
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL, Tindall GT, Kovacs K, Thorner MO, Horvath E, Hoffman JC.
    J Neurosurg; 1984 Jan 08; 60(1):1-7. PubMed ID: 6689702
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.